Abstract
Inflammatory profiling of Schwann cells manifested as an upregulation of cytokines is present after traumatic or disease injury of the peripheral nerves. Inflammatory activation of Schwann cells via Toll-like receptors (TLRs) can be triggered by exogenous pathological molecules or endogenous ligands produced during Wallerian degeneration. We investigated the early period of inflammatory reactions by following the levels of TLR4, NFκB, IL-1β, pSTAT3, and IL-6 proteins after LPS treatment of RT4 schwannoma cells under in vitro conditions. Significantly increased levels of NFκB, IL-1β, pSTAT3, and IL-6 proteins were found 1 h after LPS action indicating their involvement in the initiation of the inflammatory reaction of schwannoma cells. This initiation was induced without increased TLR4 protein expression, but was accompanied by the appearance of TLR4 in early endosomes. The protein levels decreased within the next 6 h of treatment with a subsequent increase of NFκB, IL-1β, and pSTAT3 after 24 h of LPS treatment. In contrast, continuous decrease of IL-6 over time following LPS treatment was unexpected. Levels of soluble IL-6 protein in the culture medium also decreased with decreasing levels of LPS over 24 h.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Akira S, Takeda K (2004) Toll-like receptor signalling. Nat Rev Immunol 4:499–511. doi:10.1038/nri1391
Battle TE, Frank DA (2002) The role of STATs in apoptosis. Curr Mol Med 2:381–392. doi:10.2174/1566524023362456
Bauer S, Kerr BJ, Patterson PH (2007) The neuropoietic cytokine family in development, plasticity, disease and injury. Nat Rev Neurosci. doi:10.1038/nrn2054
Benito C, Davis CM, Gomez-Sanchez JA, Turmaine M, Meijer D, Poli V, Mirsky R, Jessen KR (2017) STAT3 controls the long-term survival and phenotype of repair Schwann cells during nerve regeneration. J Neurosci. doi:10.1523/JNEUROSCI.3481-16.2017
Ben-Yaakov K, Dagan SY, Segal-Ruder Y, Shalem O, Vuppalanchi D, Willis DE, Yudin D et al (2012) Axonal transcription factors signal retrogradely in lesioned peripheral nerve. EMBO J 31:1350–1363. doi:10.1038/emboj.2011.494
Boerboom A, Dion V, Chariot A, Franzen R (2017) Molecular mechanisms involved in Schwann cell plasticity. Front Mol Neurosci 10:38. doi:10.3389/fnmol.2017.00038
Boivin A, Pineau I, Barrette B, Filali M, Vallieres N, Rivest S, Lacroix S (2007) Toll-like receptor signaling is critical for Wallerian degeneration and functional recovery after peripheral nerve injury. J Neurosci 27:12565–12576. doi:10.1523/jneurosci.3027-07.2007
Cámara-Lemarroy CR, Guzmán-de la Garza FJ, Fernández-Garza NE (2010) Molecular inflammatory mediators in peripheral nerve degeneration and regeneration. NeuroImmunoModulation 17:314–324. doi:10.1159/000292020
Campana WM (2007) Schwann cells: activated peripheral glia and their role in neuropathic pain. Brain Behav Immun 21:522–527. doi:10.1016/j.bbi.2006.12.008
Chow JC, Young DW, Golenbock TD, Christ WJ, Gusovsky (1999) Toll-like receptor-4 mediates lipopolysaccharide-induced signal transduction. J Biol Chem 274:10689–10692. doi:10.1074/jbc.274.16.10689
Dubovy P, Jancalek R, Kubek T (2013) Role of inflammation and cytokines in peripheral nerve regeneration. Int Rev Neurobiol 108:173–206. doi:10.1016/B978-0-12-410499-0.00007-1
Dubovy P, Klusakova I, Svizenska IH (2014) Inflammatory profiling of Schwann cells in contact with growing axons distal to nerve injury. Biomed Res Int 2014:1–7. doi:10.1155/2014/691041
Gadient RA, Otten UH (1997) Interleukin-6 (IL-6)—a molecule with both beneficial and destructive potentials. Prog Neurobiol 52:379–390. doi:10.1016/S0301-0082(97)00021-X
Garbers C, Hermanns HM, Schaper F, Müller-Newen G, Grötzinger J, Rose-John S, Scheller J (2012) Plasticity and cross-talk of interleukin 6-type cytokines. Cytokine Growth Factor Rev 23:85–97. doi:10.1016/j.cytogfr.2012.04.001
Gaudet AD, Popovich PG, Ramer MS (2011) Wallerian degeneration: gaining perspective on inflammatory events after peripheral nerve injury. J Neuroinflammation 8:110. doi:10.1186/1742-2094-8-110
Grivennikov SI, Karin M (2010) Inflammation and oncogenesis: a vicious connection. Curr Opin Genet Dev 20:65–71. doi:10.1016/j.gde.2009.11.004
Hao HN, Peduzzi-Nelson JD, VandeVord PJ, Barami K, DeSilva SP, Pelinkovic D, Morawa LG (2009) Lipopolysaccharide-induced inflammatory cytokine production by Schwann’s cells dependent upon TLR4 expression. J Neuroimmunol 212:26–34. doi:10.1016/j.jneuroim.2009.04.020
Hughes PM, Wells GM, Perry VH, Brown MC, Miller KM (2002) Comparison of matrix metalloproteinase expression during Wallerian degeneration in the central and peripheral nervous systems. Neuroscience 113:273–287. doi:10.1016/S0306-4522(02)00183-5
Husebye H, Halaas Ø, Stenmark H, Tunheim G, Sandanger Ø, Bogen B, Brech A et al (2006) Endocytic pathways regulate toll-like receptor 4 signaling and link innate and adaptive immunity. EMBO J 25:683–692. doi:10.1038/sj.emboj.7600991
Kano A, Wolfgang MJ, Gao Q, Jacoby J, Chai GX, Hansen W, Iwamoto Y, Pober JS, Flavell RA, Fu XY (2003) Endothelial cells require STAT3 for protection against endotoxin-induced inflammation. J Exp Med 198:1517–1525. doi:10.1084/jem.20030077
Kawai T, Akira S (2007) TLR signaling. Semin Immunol 19:24–32. doi:10.1016/j.smim.2006.12.004
Kim KS (2003) Neurological diseases: pathogenesis of bacterial meningitis: from bacteraemia to neuronal injury. Nat Rev Neurosci 4:376–385. doi:10.1038/nrn1103
Kurek JB, Austin L, Cheema SS, Bartlett PF, Murphy M (1996) Up-regulation of leukaemia inhibitory factor and interleukin-6 in transected sciatic nerve and muscle following denervation. Neuromuscul Disord. doi:10.1016/0960-8966(95)00029-1
Lam LT, Wright G, Davis RE, Lenz G, Farinha P, Dang L, Chan JW et al (2008) Cooperative signaling through the signal transducer and activator of transcription 3 and nuclear factor-κB pathways in subtypes of diffuse large B-cell lymphoma. Blood 111:3701–3713. doi:10.1182/blood-2007-09-111948
Lee HK, Seo IA, Suh DJ, Hong JI, Yoo YH, Park HT (2009a) Interleukin-6 is required for the early induction of glial fibrillary acidic protein in Schwann cells during Wallerian degeneration. J Neurochem 108:776–786. doi:10.1111/j.1471-4159.2008.05826
Lee H, Herrmann A, Deng JH, Kujawski M, Niu G, Li Z, Forman S, Jove R, Pardoll DM, Yu H (2009b) Persistently activated STAT3 maintains constitutive NF-κB activity in tumors. Cancer Cell 15:283–293. doi:10.1016/j.ccr.2009.02.015
Libermann TA, Baltimore D (1990) Activation of interleukin-6 gene expression through the NF-kappa B transcription factor. Mol Cell Biol 10:2327–2334. doi:10.1128/MCB.10.5.2327
Naugler WE, Sakurai T, Kim S, Maeda S, Kim K, Elsharkawy AM, Karin M (2007) Gender disparity in liver cancer due to sex differences in MyD88-dependent IL-6 production. Science 317:121–124. doi:10.1126/science.1140485
Pellegrino MJ, Habecker BA (2013) STAT3 integrates cytokine and neurotrophin signals to promote sympathetic axon regeneration. Mol Cell Neurosci 56:272–282. doi:10.1016/j.mcn.2013.06.005
Rathinam VA, Fitzgerald KA (2013) Immunology: lipopolysaccharide sensing on the inside. Nature 501:173–175. doi:10.1038/nature12556
Rotshenker S (2011) Wallerian degeneration: the innate-immune response to traumatic nerve injury. J Neuroinflammation 8:109. doi:10.1186/1742-2094-8-109
Sriram K, Benkovic SA, Hebert MA, Miller DB, O’Callaghan JP (2004) Induction of gp130-related cytokines and activation of JAK2/STAT3 pathway in astrocytes precedes up-regulation of glial fibrillary acidic protein in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine model of neurodegeneration. J Biol Chem 279:19936–19947. doi:10.1074/jbc.M309304200
Taga T (1996) gp130, a shared signal transducing receptor component for hematopoietic and neuropoietic cytokines. J Neurochem 67:1–10. doi:10.1046/j.1471-4159.1996.67010001.x
Taniguchi K, Karin M (2014) IL-6 and related cytokines as the critical lynchpins between inflammation and cancer. Semin Immunol 26:54–74. doi:10.1016/j.smim.2014.01.001
Thakur KK, Saini J, Mahajan K, Singh D, Jayswal DP, Mishra S, Bishyaee A, Sethi G, Kunnumakkara AB (2017) Therapeutic implications of toll-like receptors in peripheral neuropathic pain. Pharmacol Res 115:224–232. doi:10.1016/j.phrs.2016.11.019
Üçeyler N, Tscharke A, Sommer C (2008) Early cytokine gene expression in mouse CNS after peripheral nerve lesion. Neurosci Lett 436:259–264. doi:10.1016/j.neulet.2008.03.037
Vabulas RM, Ahmad-Nejad P, Costa C, Miethke T, Kirschning CJ, Häcker H, Wagner H (2001) Endocytosed HSP60s use toll-like receptor 2 (TLR2) and TLR4 to activate the toll/interleukin-1 receptor signaling pathway in innate immune cells. J Biol Chem 276:31332–31339. doi:10.1074/jbc.M103217200
Vallières N, Berard JL, David S, Lacroix S (2006) Systemic injections of lipopolysaccharide accelerates myelin phagocytosis during Wallerian degeneration in the injured mouse spinal cord. Glia 53:103–113. doi:10.1002/glia.20266
Wang T, Yuan W, Liu Y, Zhang Y, Wang Z, Zhou X, Ning G et al (2015) The role of the JAK-STAT pathway in neural stem cells, neural progenitor cells and reactive astrocytes after spinal cord injury. Biomed Rep 3:141–146. doi:10.3892/br.2014.401
Wong KM, Babetto E, Beirowski B (2017) Axon degeneration: make the Schwann cell great again. Neural Regen Res 12:518–524. doi:10.4103/1673-5374.205000
Ydens E, Lornet G, Smits V, Goethals S, Timmerman V, Janssens S (2013) The neuroinflammatory role of Schwann cells in disease. Neurobiol Dis 55:95–103. doi:10.1016/j.nbd.2013.03.005
Acknowledgements
This work was supported by grants 16-08508S of The Czech Science Foundation and the National Sustainability Programme of the Czech Ministry of Education, Youth and Sports (LO1214) and the RECETOX research infrastructure (LM2015051).
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Kohoutková, M., Korimová, A., Brázda, V. et al. Early inflammatory profiling of schwannoma cells induced by lipopolysaccharide. Histochem Cell Biol 148, 607–615 (2017). https://doi.org/10.1007/s00418-017-1601-5
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00418-017-1601-5